Joseph C Lee1,2, Marcelo Santos Teles1. 1. Department of Medical Imaging, The Prince Charles Hospital, Chermside, Queensland, 4032 Australia. 2. Faculty of Medicine, University of Queensland, Herston Rd, Herston, Queensland, 4006 Australia.
Dear Editor,We entirely agree with the conclusions of Tibana et al.([1]). Although false-positives
can occur with 18F-fluorodeoxyglucose positron emission tomography/computed
tomography (PET/CT), the prevalence of true-positives cannot be underestimated.
Additional primary malignancies may often be identified by this means and the likelihood
of cure is much increased if such malignancies are treated promptly and aggressively. It
was unclear what is the actual prevalence of malignancies discovered with PET/CT in this
study.The prevalence of additional malignancies discovered with PET/CT was highlighted in the
various systems for breast([2]), bowel([3]), prostate([4]) and thyroid([5]) lesions. For example, in a
study of 1665 patients, 70 incidentally detected lesions in the colon were identified
and eventually 10 were diagnosed with bowel carcinoma([3]). There were additional
pre-malignant lesions identified and early treatment was warranted in this scenario.
Thus, it was found the prevalence of malignant and pre-malignant findings in the PET
population was about 1.3%. A similar series showed a lower number of carcinomas but more
adenomas (which would, of course, be considered pre-malignant) in a slightly larger
series([6]).
Hence, the prevalence was similar (at 1.1%). Knowing the prevalence may give a better
idea of the importance of the incidental findings. This would be very helpful for both
managing the individual patient as well as for public health and population health
purposes.
Authors: Ehab M Kamel; Miriam Thumshirn; Kaspar Truninger; Marc Schiesser; Michael Fried; Barbara Padberg; Didier Schneiter; Sandro J Stoeckli; Gustav K von Schulthess; Katrin D M Stumpe Journal: J Nucl Med Date: 2004-11 Impact factor: 10.057